Bioanalysis Zone

Validation of an ultrasensitive LC–MS/MS method for PTH 1–34 in porcine plasma to support a solid dose PK study


Background: The bioanalysis of Teriparatide (PTH 1–34) is extremely challenging due to the low plasma concentrations present at a therapeutic level. An LC–MS/MS-based method was developed that detected PTH 1–34 at 15 pg/ml in porcine plasma, and was validated using the bioanalytical method validation guidelines. Results: The analytical methodology demonstrated good linearity over a range of 15–1000 pg/ml, and demonstrated good precision and accuracy. The validated method was used to support a trial comparing a solid state dose to a solution-based injection (Forteo™). Conclusion: The ability to quantify the peptide at low pg/ml in porcine plasma demonstrates that it is possible to develop very sensitive LC–MS/MS-based methodologies to support the bioanalysis of large peptide biotherapeutics.

To view restricted content, please:

Leave A Comment

Please wait...

Bioanalysis Zone New Investigator Award

Why not start this year by doing something good by nominating an early career scientist for the Bioanalysis Zone New Investigator Award. Complete the details below to register your interest!